Rocky Mountain Clinical Research, Inc. is dedicated to provide services to physicians, pharmaceutical companies and corporations in phase II, III and IV clinical trials in accordance with FDA, GCP’s and sponsor regulations. We work with select groups of physicians who have multiple sites with large databases. Our experience ranges from consortia to one-site private practice physicians.

Research Strengths:

• Network/Communicate/Consult
• Securing and placing trials
• Negotiate and manage budgets
• Coordinate consortia, Multi-Sites and Existing Sites
• Provide services required to institute protocols
• Generate Reports at defined times
• Versed in local and central IRB’s
• Develop source documents
• Design and maintain research databases
• Consulting services are available in research, as well as other medically related endeavors.

Rocky Mountain Clinical Research, Inc. is a Golden, Colorado based Corporation in good standing providing services to pharmaceutical companies and physicians in clinical research. Purchased as Rocky Mountain Heart Research Associates, Inc, in November of 1995, it has been in existence as a research corporation for more than a decade, formerly known as the Rocky Mountain Heart Institute. The name was legally changed to Rocky Mountain Clinical Research, Inc., November of 1996.

Rocky Mountain Clinical Research works with each individual patient acknowledging his or her different medical conditions. We embrace every opportunity to participate in clinical research studies that can change the lives of those patients and help provide safe and effective clinical research.

As a clinical research center, we have 16 years of research experience, seven of those years performing industry-sponsored clinical trials at the University of Colorado Health Sciences Center including National Institute of Health (NIH) Protocols. While having worked directly with numerous pharmaceutical companies:

Amgen, Inc., Astra Merck, Astra Zeneca, Bayer, Boehringer Ingelheim, Bristol-Myer Squibb, Chiron Diagnostics, DuPont Merck, DuPont Pharma, Glaxo-Wellcome, ICOS, Janssen, Medtronics, National Genetics Institute, Neurex/Elan, Proctor & Gamble, Purdue Pharma, Roche, Sandhill Scientific, Sankyo, Searle, Schering-Plough, Bertek Pharma, DepoMed, Inc., GlaxoSmithKline, Elan Pharma, Fujisawa, Isis Pharma, Merck, Novartis, NPS Allelix Cord, SciClone, Sepracore, Shire, Solvay and Wyeth Ayerst..

We have also provided services for several CRO’s, SMO’s, and Independent Monitering groups including:

Bioresearch Monitors, Inc., Cary Paul Co., Clinimetrics, Culbertson Research Assoc. Inc., Duke University, Hardardt Group, Kendle, Kern McNeill International, Medifacts Research Services, Monitech Services, Parexel, Premier Research Assoc., Pro re nata Consultants, Quintiles, Scirex, Space Labs, Sroka and Co., West Pharmaceuticals.

Our clinical research experience includes studies in the following therapeutic areas:

• Cardiac and GI Device Trials
• Cardiology
• Endocrine
• Gastrointestinal/Hepatology
• Hypertension
• Infectious Disease
• Pain Management
• Rheumatology

We have worked with the following Institutional Review Boards:
Local:
COMIRB, HealthOne, Littleton/Porter Adventist Hospital Joint IRB, North Colorado Medical Center IRB (Greeley), Poudre Valley Hospital IRB, Rocky Mountain Heart Consortium IRB, Rose Medical Center IRB, St. Anthony Hospitals IRB and UCHSC-IRB.

Central: Essex IRB, Ethical Review Committee IRB, Quintiles IRB, Schulman IRB, Western IRB, New England IRB, Research Consultants Review Committee, The Copernicus Group IRB and Quorum Review IRB.

We are adept in managing all aspects of single-site, multi-site, in-patient and outpatient clinical trials. Our flexibility with local and Central Institutional Review Boards produces results pharmaceutical companies desire: clean, quality data presented on time and on budget.

The administrative office is located at 29 Rogers Court - with full time support staff in 1500 Sq. Feet of space.

Our equipment consists of 6 computers, fax, 5 printers, 1-Copy machine with sorter and multiplex copying, 1- minus 24 freezer, 1- refrigerator, 1- centrifuge, 3- phlebotomy trays, 2- blood pressure machines, 3-ECG machines.

All patients are seen at the investigator’s offices with a full complement of office staff and equipment. Patients are seen during regular office hours with investigators available when issues present.

Our office location is in Golden, Colorado which is to the West of Denver near the foothills. We have immediate access to I-70, C-470, and 6th Ave. freeways, which puts us within 15 min. of downtown Denver and less than an hour to Denver International Airport. The accommodations are close and include some very nice motels and also some very upscale hotels with everything else in-between.

Since the full list of investigators would be overwhelming, the following list is of the ongoing and just closed studies. The investigator’s are:

Maurice Archuleta, MD
Internal Medicine/Family Practice

Bahri Bilir, MD
Gastroenterology/Hematology

Paul Douglas Deneault, MD
Gastroenterology/Hepatology

John S. Goff, MD
Gastroenterology/Hepatology

Richard Hansen, MD
Gastroenterology/Hepatology

Stuart S. Kassan, MD
Rheumatology

Richard A. Rein, MD
Gastroenterology/Hepatology

Lee K. Richman, MD
Gastroenterology/Hepatology

Alan L. Rosenberg, MD
Rheumatology

Judy Weiss, MD
Rheumatology

Theresa Scholz, MD, MBA
Dermatology

Flory Kreutter, MD
Internal Medicine/Family Practice

Noray Bilir, MD
Gastroenterology/Hepatology

Andrzej Triebling, MD
Gastroenterology

Stephen P. Lawrence, MD, FACP
Gastroenterology

R. Matthew Reveille, MD
Gastroenterology/Hepatology

Rajesh Jain, MD
Gastroenterology/Hepatology

Gail Danhour, RN, CCRC

• Executive Director; Clinical research experience since 1987.
• Training: Cardiovascular, Surgery, ICU, GI/Hepatology, Pain Management.

Melissa Skahan, RN, BSN

• Research Coordinator since 2003
• Training:

Tammy Vincze, CCRC

• Research Coordinator, Clinical research experience since 1993.
• Training: Phlebotomy, GI/Hepatology, Cardiovascular, Rheumatology, Pain Management.

Joanne Wilson, BSMT, CCRC, MBA

• Research Coordinator/Directory of Finance and Marketing
• Training: Phlebotomy, Med Tech, Microbiology

James Friend, BS, CCRC

• Research Coordinator
• Training: Phlebotomy, Phase I Research, Lab-Tech

Marylyn Baker, CCRC

• Research Coordinator
• Training: Phlebotomy

The Denver Metro Area consists of over 2 million people from all walks of life. The ethnic breakdown follows an average western city with the largest minority being Hispanic and smaller numbers of Blacks and Asians.

We have placed studies within specific groups and have also diversified to include subjects with PI’s in Ft. Collins and Greeley and as far south as Colorado Springs.

We draw subjects from the Investigator’s databases as well as our own. We also advertise and use the Internet to make subjects aware of the possibilities for research studies.

Rocky Mountain Clinical Research has a current and continuing positive retained earnings. The company has shown growth since the purchase in 1995 with net assets increasing by 33% annually. Management has 25 years of experience.

Current Dunn & Bradstreet number is 11-115-2138, with a positive report.

We at Rocky Mountain Clinical Research believe research has become very complex. Our standard to assure success include these four ideals.

The first is identification of study opportunities. This critical area provides a means by which the physician, our staff and the patient can contribute to advances in therapy.
The second step is devotion. Our staff is devoted full-time to assuming responsibilities in clinical research, from the regulatory issues to providing patient care.
The third step is providing protocols to community physicians who have served as Principal or Sub-Investigators in clinical trials since going into practice. These physicians enjoy providing the "extra" opportunity and care to their patients and play an intricate role in the completion of a protocol.
The fourth step is time commitment. For research to be a success, it must be supported seven days a week. We provide 24-hour, seven-days-per-week coverage for all protocols.

CenterWatch is listing the following trials that are actively recruiting patients at this center.

• A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects with Moderately Active Crohn’s Disease.
• Active Crohn's Disease: International, Multicenter, Double-Blind, Placebo-controlled study for moderate to severe Crohn's Disease.
• An investigational research trial to assess the safety and efficacy of a study drug in patients with active Crohn's disease.
• Females with diarrhea-predominant Irritable Bowel Syndrome (IBS): A 16 week, randomized, placebo-controlled study to assess the Safety of different doses of an investigational medication.
• Multi-Center, Placebo-Controlled study of safety and efficacy for Diarrhea Predominant IBS with a highly specific and selective oral 5-HT₃ receptor antagonist.

For more information, please contact:

Gail E. Danhour, RN, CCRC
Executive Director
Rocky Mountain Clinical Research, Inc.
29 Rogers Court
Golden, CO 80401 USA
Phone: 303-279-1550
Fax: 303-278-2602
E-mail:

If you are interested in contacting this center to discuss placing a clinical trial there, please complete and send the E-mail form below. A representative from the research center will then follow up with you.

Name:
Address:
City:
State:
Zip:
Phone:
Email address:
Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

Last updated on August 21, 2008